PubMedCrossRef 9. Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia?
An open-label study with controls. J Am Geriatr Soc. 2009;57:359–60.PubMedCrossRef 10. Chung KA, Lobb BM, Nutt JG, Horak FB. CX-5461 nmr Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75:1263–9.PubMedCentralPubMedCrossRef 11. Montero-Odasso M, Wells JL, Borrie MJ, Speechley M. Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial. BMC Neurol. 2009;9:42.PubMedCentralPubMedCrossRef 12. Henderson EJ, Lord SR, Jacqueline CT, Close JCT, Lawrence AD, Whone E, Ben-Shlomo Y. The ReSPonD trial: rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen. BMC Neurol. 2013;13:188.PubMedCentralPubMedCrossRef
13. Cummings JL. Cholinesterase inhibitors: a new class this website of psychotropic compounds. Am J Psychiatry. 2000;157(1):4–15.PubMed 14. Nutt JG, Horak FB, Bloem BR. Milestones in gait, balance, and falling. Mov Disord. 2011;26:1166–74.PubMedCrossRef 15. Chastan N, Do MC, Bonneville F, Torny F, Bloch F, Westby GW, et al. Gait and balance disorders in Parkinson’s disease: impaired active braking of the fall of centre cAMP of gravity. Mov Disord. 2009;24:188–95.PubMedCrossRef 16. Snijders AH, Leunissen I, Bakker M, Overeem S, Helmich RC, Bloem BR, Toni I. Gait-related
cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain. 2011;134:59–72.PubMedCrossRef 17. Karachi C, Grabli D, Bernard FA, Tandé D, Wattiez N, Belaid H. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Investig. 2010;120:2745–54.PubMedCentralPubMedCrossRef 18. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef 19. Shiekh J, Yesavage J. Geriatric Depression Scale: recent findings and development of a short version Clinical Gerontology: a guide to assessment and intervention. New York: Howard Press; 1986. 20. Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) scale. J Selleck Selonsertib Gerontol A Biol Sci Med Sci. 1995;50A:M28–34.PubMedCrossRef 21. Spielberger CD, Gorsuch RL, Kushene RP, Vagg R, Jacobs GA. State-trait anxiety inventory: self-evaluation questionnaire (form y) In: Spielberger CD, editor. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologist Press; 1983 22. Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, et al. Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. J Mol Neurosci. 2004;24:33–44.PubMedCrossRef 23. Podsiadlo D, Richardson S.